Category:
Prophylactic Biological Products
CAS NO:
1613316-39-4
Standard:
In-house Standards,
Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
Cabazitaxel Monohydrate is a third-generation taxane chemotherapy agent produced via semi-synthetic organic synthesis. Its molecular formula is C45H53NO12, and it carries CAS No. 908764-43-2.
Strictly contraindicated for patients with severe neutropenia or hypersensitivity to cabazitaxel. Store in sealed containers at 2°C to 8°C protected from light and moisture to maintain chemical stability.